WASHINGTON (dpa-AFX) - Below are the earnings highlights for Alnylam Pharmaceuticals Inc. (ALNY):
Earnings: $147.75 million in Q3 vs. -$405.92 million in the same period last year. EPS: $1.15 in Q3 vs. -$3.32 in the same period last year. Excluding items, Alnylam Pharmaceuticals Inc. reported adjusted earnings of $228.53 million or $1.74 per share for the period.
Analysts projected -$1.36 per share Revenue: $750.53 million in Q3 vs. $264.31 million in the same period last year.
Copyright(c) 2023 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
© 2023 AFX News